Who We Are
We provide identified and diverse participants an opportunity to positively effect society via an IRB approved study at a FDA registered facility. With thousands of samples in our database, and drawing on more than 70 years of blood banking experience, CDI cultivates partnerships between the community, research, and manufacturing industry.
With robust process controls aiding in repeatable results, CDI caters to those partners who need starting material of the highest standards. We work with our partners to successfully meet their distinct documentation requirements. We operate in full support of our partners’ development from RUO to GMP compliance for Investigational Drug Applications.
Mission, Vision, and Values
Jacob C. Potter
Since 2021, Jacob has been providing broad strategic leadership to all facets of CDI’s operations including but not limited to Process Improvement, Protocol Development, and Partnership Alignment. He is passionate and committed to the end game of Cell and Gene therapies when more curative options will become available.
Coming from a diverse background in Ambulatory Operations, Jacob has supported diverse stakeholder success through operation expansion, multi-specialty program development, technology implementation, and graduate medical education. Jacob holds a Bachelor’s degree from Rollins College and both a MBA and MHA from Georgia State’s Robinson College of Business.
Process & Documentation Inquires – email Jacob.Potter@cdiblood.com
Tim oversees the Quality and Regulatory Affairs team and leads our interactions with regulatory and accreditation agencies. The Quality team is responsible for Clinical Discovery Institute compliance across its international delivery footprint, ensuring that our starting material is not called to questioned during later client regulatory review.
Tim began his career in Quality over 35 years ago in diagnostics. That was later followed by device and pharma experience and finally with blood industry experience with the ARC, Versiti, and most recently, at the innovative Secure Transfusion Services.
Tim holds a Bachelor of Science in Microbiology from the University of Minnesota.
Sarah and her team lead quality based processes within CDI’s regulatory and research framework. Her contributions touch the spectrum of the organization including Protocol Support, Participant Safety, and all reporting derived from Validated Systems.
With over 20 years of experience working with human biologics manufacturing, Sarah’s background in Project Management, Quality Assurance, and Regulated Systems development compliments our approach to meeting high standards of tailored product delivery.